BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25165471)

  • 1. Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis.
    Zhu R; Yang J; Xu L; Dai W; Wang F; Shen M; Zhang Y; Zhang H; Chen K; Cheng P; Wang C; Zheng Y; Li J; Lu J; Zhou Y; Wu D; Guo C
    Gastroenterol Res Pract; 2014; 2014():529314. PubMed ID: 25165471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta-analysis.
    Zhang Y; Tang J; Zhou X; Zhu SL; Li LQ
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1071. PubMed ID: 31777190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of des-γ-carboxy prothrombin (DCP) for hepatocellular carcinoma: a bivariate meta-analysis.
    Gao P; Li M; Tian QB; Liu DW
    Neoplasma; 2012; 59(2):150-9. PubMed ID: 22248272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis.
    Chen J; Wu G; Li Y
    Dis Markers; 2018; 2018():8906023. PubMed ID: 30402170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis.
    Yang J; Li J; Dai W; Wang F; Shen M; Chen K; Cheng P; Zhang Y; Wang C; Zhu R; Zhang H; Zheng Y; Wang J; Xia Y; Lu J; Zhou Y; Guo C
    Exp Ther Med; 2015 Apr; 9(4):1413-1420. PubMed ID: 25780444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma.
    De J; Shen Y; Qin J; Feng L; Wang Y; Yang L
    Medicine (Baltimore); 2016 Apr; 95(17):e3448. PubMed ID: 27124038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review.
    Li C; Zhang Z; Zhang P; Liu J
    Hepatol Res; 2014 Oct; 44(10):E11-25. PubMed ID: 23834468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis.
    Wang X; Zhang Y; Yang N; He H; Tao X; Kou C; Jiang J
    Biomed Res Int; 2020; 2020():5087643. PubMed ID: 33015170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
    Hu B; Tian X; Sun J; Meng X
    Int J Mol Sci; 2013 Dec; 14(12):23559-80. PubMed ID: 24317431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis.
    Zhang J; Zhao Y; Yang Q
    Int J Biol Markers; 2014 Dec; 29(4):e403-10. PubMed ID: 24980448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
    Huang TS; Shyu YC; Turner R; Chen HY; Chen PJ
    Syst Rev; 2013 Jun; 2():37. PubMed ID: 23738605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis: an updated meta-analysis.
    Dai Y; Feng Y; Xu R; Xu W; Lu W; Wang J
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3127-37. PubMed ID: 22833244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Lin S; Hu S; Ran Y; Wu F
    Transl Cancer Res; 2021 Apr; 10(4):1667-1678. PubMed ID: 35116492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
    Zhao S; Long M; Zhang X; Lei S; Dou W; Hu J; Du X; Liu L
    Ann Transl Med; 2020 Apr; 8(8):536. PubMed ID: 32411759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Circulating Cell-Free DNA to Diagnose Hepatocellular Carcinoma in Chinese Population: A Systematic Review and Meta-Analysis.
    Aalami AH; Aalami F; Aliabadi EK; Amirabadi A; Sahebkar A
    Curr Med Chem; 2023 Jun; ():. PubMed ID: 37349993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis.
    Sun T; Tang Y; Sun D; Bu Q; Li P
    Onco Targets Ther; 2018; 11():8925-8935. PubMed ID: 30573979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of des-gamma-carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse
    Sultanik P; Ginguay A; Vandame J; Popovici T; Meritet JF; Cynober L; Pol S; Bories PN
    J Viral Hepat; 2017 Jan; 24(1):80-85. PubMed ID: 27699936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological tumor markers of hepatocellular carcinoma: a meta-analysis.
    Hussein TD
    Int J Biol Markers; 2015 Feb; 30(1):e32-42. PubMed ID: 25450646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic accuracy of HE4 in lung cancer: a meta-analysis.
    Cheng D; Sun Y; He H
    Dis Markers; 2015; 2015():352670. PubMed ID: 25873748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the value of serum des-γ-carboxy prothrombin in predicting hepatocellular carcinoma recurrence after liver transplantation].
    Xu Y; Wang PX; Cheng JW; Huang XW; Zhou J; Fan J; Yang XR
    Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):918-923. PubMed ID: 33256276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.